{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:17:21Z","timestamp":1787019441111,"version":"build-2736575974"},"reference-count":133,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Amgen (Europe) GmbH"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["MDM Policy &amp; Practice"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>Background. We aimed to develop and validate a conceptual model of multiple myeloma (MM) that characterizes the attributes affecting disease progression and patient outcomes, and the relationships between them. Methods. Systematic and targeted literature reviews identified disease- and patient-specific attributes of MM that affect disease progression and outcomes. These attributes were validated by a Delphi panel of four international MM experts, and a physician-validated model was constructed. Real-world clinical data from the Czech Registry of Monoclonal Gammopathies (RMG) was used to confirm the relationships between attributes using pairwise correlations and multiple Cox regression analysis. Results. The Delphi panel reached consensus that most cytogenetic abnormalities influenced disease activity, which results in symptoms and complications and affects overall survival (OS). Comorbidities and complications also affect OS. The entire panel agreed that quality of life was influenced by comorbidities, age, complications, and symptoms. Consensus was not reached in some cases, in particular, the influence of del(17p) on complications. The relationships between attributes were confirmed using pairwise analysis of real-world data from the Czech RMG; most of the correlations identified were statistically significant and the strength of the correlations changed with successive relapses. Czech RMG data were also used to confirm significant predictors of OS included in the model, such as age, Eastern Cooperative Oncology Group performance status, and extramedullary disease. Conclusions. This validated conceptual model can be used for economic modeling and clinical decision making. It could also inform the development of disease-based models to explore the impact of disease progression and treatment on outcomes in patients with MM.<\/jats:p>","DOI":"10.1177\/2381468318814253","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T01:03:11Z","timestamp":1547773391000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":11,"title":["Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making"],"prefix":"10.1177","volume":"4","author":[{"given":"Sebastian","family":"Gonzalez-McQuire","sequence":"first","affiliation":[{"name":"Amgen (Europe) GmbH, Rotkreuz Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios-Athanassios","family":"Dimopoulos","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens School of Medicine, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Weisel","sequence":"additional","affiliation":[{"name":"University Hospital of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Bouwmeester","sequence":"additional","affiliation":[{"name":"Pharmerit International, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"H\u00e1jek","sequence":"additional","affiliation":[{"name":"Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic"},{"name":"Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Campioni","sequence":"additional","affiliation":[{"name":"Amgen (Europe) GmbH, Rotkreuz Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Bennison","sequence":"additional","affiliation":[{"name":"Pharmerit Ltd, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Xu","sequence":"additional","affiliation":[{"name":"Pharmerit International, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystallia","family":"Pantiri","sequence":"additional","affiliation":[{"name":"Pharmerit International, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"Hensen","sequence":"additional","affiliation":[{"name":"Pharmerit International, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens School of Medicine, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Knop","sequence":"additional","affiliation":[{"name":"W\u00fcrzburg University Medical Center, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"bibr1-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/232546"},{"key":"bibr2-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq370"},{"issue":"4","key":"bibr3-2381468318814253","volume":"20","author":"De Raeve HR","year":"2005","journal-title":"Histol Histopathol"},{"key":"bibr4-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13537"},{"key":"bibr5-2381468318814253","unstructured":"Cancer Research UK. Myeloma survival statistics 2010\u2013 2011 [cited November 26, 2015]. Available from: http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/myeloma\/survival#heading-Zero"},{"key":"bibr6-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14193"},{"key":"bibr7-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-010-9542-z"},{"key":"bibr8-2381468318814253","doi-asserted-by":"publisher","DOI":"10.4065\/79.7.867"},{"key":"bibr9-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.196"},{"key":"bibr10-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2012.05.003"},{"key":"bibr11-2381468318814253","unstructured":"Janssen-Cilag International NV. VELCADE summary of product characteristics [cited December 2, 2015]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000539\/WC500048471.pdf"},{"key":"bibr12-2381468318814253","unstructured":"Amgen Europe BV. Kyprolis summary of product characteristics [cited August 2, 2016]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/003790\/WC500197692.pdf"},{"key":"bibr13-2381468318814253","unstructured":"Takeda Pharma A\/S. Ninlaro summary of product characteristics [cited December 16, 2016]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/003844\/WC500217620.pdf"},{"key":"bibr14-2381468318814253","unstructured":"Celgene Europe Limited. Thalidomide Celgene summary of product characteristics [cited December 2, 2015]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000823\/WC500037050.pdf"},{"key":"bibr15-2381468318814253","unstructured":"Celgene Europe Limited. Revlimid summary of product characteristics [cited December 2, 2015]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000717\/WC500056018.pdf"},{"key":"bibr16-2381468318814253","unstructured":"Celgene Europe Limited. Imnovid summary of product characteristics [cited December 2, 2015]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002682\/WC500147717.pdf"},{"key":"bibr17-2381468318814253","unstructured":"Janssen-Cilag International NV. DARZALEX summary of product characteristics [cited August 8, 2016]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/004077\/WC500207296.pdf"},{"key":"bibr18-2381468318814253","unstructured":"Bristol-Myers Squibb Pharma EEIG. Empliciti summary of product characteristics [cited August 8, 2016]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/003967\/WC500206673.pdf"},{"key":"bibr19-2381468318814253","unstructured":"Novartis Europharm Limited. Farydak summary of product characteristics [cited August 8, 2016]. Available from: http:\/\/ec.europa.eu\/health\/documents\/community-register\/2015\/20150828132600\/anx_132600_en.pdf"},{"key":"bibr20-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.06.016"},{"key":"bibr21-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2644-6"},{"key":"bibr22-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.06.012"},{"key":"bibr23-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X16662009"},{"key":"bibr24-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.4514.4514"},{"key":"bibr25-2381468318814253","volume-title":"NICE DSU Technical Support Document 13: Identifying and Reviewing Evidence to Inform the Conceptualisation and Population of Cost-Effectiveness Models","author":"Kaltenthaler E","year":"2011"},{"issue":"10","key":"bibr26-2381468318814253","first-page":"1","volume":"12","author":"Hsu CC","year":"2007","journal-title":"Pract Assess Res Eval"},{"key":"bibr27-2381468318814253","unstructured":"H\u00e1jek R, Jarkovsky J, Maisnar V, et al. Survival and treatment patterns in patients with symptomatic multiple myeloma (MM) in a real-world setting. Poster presented at: European Hematology Association 21st Annual Meeting; June 9\u201312, 2016; Copenhagen."},{"key":"bibr28-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.3607.3607"},{"key":"bibr29-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.4.1147"},{"key":"bibr30-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.03.004"},{"key":"bibr31-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14213"},{"key":"bibr32-2381468318814253","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1041386"},{"key":"bibr33-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-615187"},{"key":"bibr34-2381468318814253","unstructured":"Bird JM Owen RG, D\u2019Sa S, et al. Guidelines for the diagnosis and management of multiple myeloma 2014 [cited March 2015]. Available from: https:\/\/academy.myeloma.org.uk\/wp-content\/uploads\/sites\/2\/2014\/08\/MYELOMA_GUIDELINE_Feb_2014_for_BCSH1.pdf"},{"key":"bibr35-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt297"},{"key":"bibr36-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607113350204"},{"key":"bibr37-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022340"},{"key":"bibr38-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22921"},{"key":"bibr39-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.07.022"},{"key":"bibr40-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01533.x"},{"key":"bibr41-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-631200"},{"key":"bibr42-2381468318814253","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.099358"},{"key":"bibr43-2381468318814253","unstructured":"National Institute for Health and Care Excellence. The guidelines manual 2012 [cited July 9, 2015]. Available from: https:\/\/www.nice.org.uk\/process\/pmg6\/chapter\/introduction"},{"issue":"1","key":"bibr44-2381468318814253","volume":"31","author":"Aurer I","year":"2007","journal-title":"Coll Antropol"},{"key":"bibr45-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.5317.5317"},{"key":"bibr46-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1179\/102453311X13127324303399"},{"key":"bibr47-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.1862.1862"},{"key":"bibr48-2381468318814253","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1515\/cclm-2013-0406","volume":"52","author":"de Veas Silva JG","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"bibr49-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.3150.3150"},{"issue":"21","key":"bibr50-2381468318814253","volume":"122","author":"Esteves G","year":"2013","journal-title":"Blood"},{"key":"bibr51-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.4976.4976"},{"key":"bibr52-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07303.x"},{"key":"bibr53-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.56"},{"key":"bibr54-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.03.004"},{"key":"bibr55-2381468318814253","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2013.33.4.248"},{"key":"bibr56-2381468318814253","volume":"31","author":"Kienle DL","year":"2013","journal-title":"Hematol Oncol"},{"key":"bibr57-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.3092.3092"},{"issue":"21","key":"bibr58-2381468318814253","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.2136.2136","volume":"122","author":"Painuly U","year":"2013","journal-title":"Blood"},{"issue":"6","key":"bibr59-2381468318814253","volume":"24","author":"Panani AD","year":"2004","journal-title":"Anticancer Res"},{"key":"bibr60-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09124.x"},{"key":"bibr61-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp175"},{"key":"bibr62-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2004.230"},{"key":"bibr63-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2013-0015"},{"key":"bibr64-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2012.01792.x"},{"key":"bibr65-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V116.21.3033.3033"},{"issue":"9","key":"bibr66-2381468318814253","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.24959","volume":"116","author":"Rossi D","year":"2010","journal-title":"Cancer"},{"key":"bibr67-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.32.15_suppl.e17694"},{"key":"bibr68-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.1946.1946"},{"key":"bibr69-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V116.21.934.934"},{"key":"bibr70-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.5365.5365"},{"key":"bibr71-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0841-4"},{"key":"bibr72-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.4978.4978"},{"key":"bibr73-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.1916.1916"},{"key":"bibr74-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V118.21.3936.3936"},{"key":"bibr75-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.31.15_suppl.8586"},{"key":"bibr76-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.30.15_suppl.8093"},{"key":"bibr77-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.30.15_suppl.8037"},{"key":"bibr78-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.3182.3182"},{"key":"bibr79-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2013.07.008"},{"key":"bibr80-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-006-0095-3"},{"key":"bibr81-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2011.01729.x"},{"issue":"6","key":"bibr82-2381468318814253","first-page":"631","volume":"28","author":"Ramsenthaler C","year":"2014","journal-title":"Palliat Med"},{"key":"bibr83-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.32.15_suppl.e19580"},{"key":"bibr84-2381468318814253","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000319736","volume":"33","author":"Bruns I","year":"2010","journal-title":"Onkologie"},{"key":"bibr85-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1097\/NCC.0b013e3181f9904d"},{"key":"bibr86-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.30.15_suppl.e18556"},{"issue":"5","key":"bibr87-2381468318814253","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0609.2008.01126.x","volume":"81","author":"Strasser-Weippl K","year":"2008","journal-title":"Eur J Haematol"},{"key":"bibr88-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1097\/01.coc.0000045810.91816.41"},{"key":"bibr89-2381468318814253","first-page":"S611","volume":"37","author":"Begovic D","year":"2013","journal-title":"Biochim Clin"},{"key":"bibr90-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0061"},{"key":"bibr91-2381468318814253","unstructured":"Abd El-Aziz A, Hanafy SM, El-Sayed IH, El Sorady M, El Soud SA. Osteoprotegerin gene expression in multiple myeloma patients. Abstract presented at: the International Conference on Bioscience, Biotechnology, and Biochemistry; Rome, Italy; April 28\u201330, 2010."},{"key":"bibr92-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.3133.3133"},{"key":"bibr93-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V114.22.4892.4892"},{"key":"bibr94-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.08.034"},{"key":"bibr95-2381468318814253","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.538775"},{"key":"bibr96-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.1910.1910"},{"key":"bibr97-2381468318814253","doi-asserted-by":"publisher","DOI":"10.2174\/22115528113026660012"},{"key":"bibr98-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27387"},{"key":"bibr99-2381468318814253","first-page":"2","volume":"8","author":"Andrade VC","year":"2008","journal-title":"Cancer Immun"},{"key":"bibr100-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.5004.5004"},{"key":"bibr101-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.4005.4005"},{"key":"bibr102-2381468318814253","first-page":"568","volume":"95","author":"Calder\u00f3n C","year":"2010","journal-title":"Haematologica"},{"key":"bibr103-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.2932.2932"},{"key":"bibr104-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.124.124"},{"key":"bibr105-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V118.21.1824.1824"},{"issue":"2","key":"bibr106-2381468318814253","volume":"29","author":"Durak BA","year":"2012","journal-title":"Turk J Haematol"},{"key":"bibr107-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.32.15_suppl.e17554"},{"key":"bibr108-2381468318814253","unstructured":"Fonti R, Larobina M, De Luca S, et al. Metabolic tumor volume assessed by 18F-FDG-PET\/CT in the evaluation of plasma cell mass and prediction of outcome in patients with multiple myeloma. Poster presented at: 23rd Annual Congress of the European Association of Nuclear Medicine (EANM); October 9\u201313, 2010; Vienna, Austria."},{"key":"bibr109-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31825b32bc"},{"key":"bibr110-2381468318814253","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3324\/haematol.2009.010017","volume":"95","author":"Heintel DH","year":"2010","journal-title":"Haematologica"},{"key":"bibr111-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500286218"},{"key":"bibr112-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1007\/BF02850052"},{"key":"bibr113-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.31.15_suppl.e19500"},{"key":"bibr114-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.3100.3100"},{"key":"bibr115-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.32.15_suppl.e19585"},{"key":"bibr116-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.30.15_suppl.8097"},{"key":"bibr117-2381468318814253","first-page":"388","volume":"94","author":"Maltezas D","year":"2009","journal-title":"Haematologica"},{"key":"bibr118-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.31.15_suppl.e19522"},{"key":"bibr119-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V116.21.1929.1929"},{"key":"bibr120-2381468318814253","first-page":"387","volume":"95","author":"Tsirakis G","year":"2010","journal-title":"Haematologica"},{"key":"bibr121-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.32.15_suppl.e19588"},{"key":"bibr122-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06481.x"},{"key":"bibr123-2381468318814253","volume":"29","author":"Himani B","year":"2013","journal-title":"Indian J Hematol Blood Transfus"},{"key":"bibr124-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.02.017"},{"key":"bibr125-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2011.01.010"},{"key":"bibr126-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V118.21.3922.3922"},{"issue":"8","key":"bibr127-2381468318814253","volume":"24","author":"Sampaio MS","year":"2009","journal-title":"Histol Histopathol"},{"key":"bibr128-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.07.014"},{"key":"bibr129-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.30.15_suppl.8091"},{"key":"bibr130-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.30.15_suppl.9083"},{"key":"bibr131-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.30.15_suppl.9082"},{"key":"bibr132-2381468318814253","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.3967.3967"},{"key":"bibr133-2381468318814253","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3324\/haematol.2008.000638","volume":"94","author":"Terpos E","year":"2009","journal-title":"Haematologica"}],"container-title":["MDM Policy &amp; Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2381468318814253","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2381468318814253","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2381468318814253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T18:00:11Z","timestamp":1741024811000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2381468318814253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":133,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1177\/2381468318814253"],"URL":"https:\/\/doi.org\/10.1177\/2381468318814253","relation":{},"ISSN":["2381-4683","2381-4683"],"issn-type":[{"value":"2381-4683","type":"print"},{"value":"2381-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"article-number":"2381468318814253"}}